Jeon D G, Kawai A, Boland P, Healey J H
Department of Orthopaedic Surgery, Korea Cancer Center Hospital, Seoul, Korea.
Clin Orthop Relat Res. 1999 Jan(358):15-26.
Complications are common among patients treated for malignant lesions of the proximal tibia and can be difficult to manage. This investigation was a retrospective review of 40 patients treated with total knee replacements after proximal tibial resections. Various reconstructive methods were used to fix the prosthetic stems, reestablish the extensor mechanism, and provide soft tissue coverage. Thirty-one patients had adequate followup to allow for review of prosthetic outcome (means, 78 months; range, 25-193 months). Seven patients died with less than 2 years followup, and two patients had postoperative acute infections treated by early amputation to allow chemotherapy to resume promptly. The overall 5-, 8-, and 12-year event free prostheses survival rates were 62%, 33%, and 16%, respectively. Prognostic factors for prosthetic survival were analyzed (age, gender, type of excision, type of prosthesis, type of fixation, and percent of bone resected). None were statistically significant. Patients with less than 40% of the tibia resected had better prosthetic survival at 5 years. The durability of uncemented stem fixation exceeded that of cemented stems. Expected survival of prostheses after revision was 52% at 8 years. The major cause of limb loss was infection. Failure to reconstruct soft tissues satisfactorily caused most failures. Aggressive multistage management of infection is needed. Prosthetic knee replacement is most suitable for patients with cancers that require chemotherapy and for those patients who have short potential survival.
胫骨近端恶性病变患者并发症常见且难以处理。本研究回顾性分析了40例胫骨近端切除术后行全膝关节置换术的患者。采用多种重建方法固定假体柄、重建伸膝装置并提供软组织覆盖。31例患者获得足够随访以评估假体效果(平均78个月;范围25 - 193个月)。7例患者随访不足2年死亡,2例患者术后发生急性感染,早期截肢以尽快恢复化疗。假体5年、8年和12年无事件生存率分别为62%、33%和16%。分析了假体生存的预后因素(年龄、性别、切除类型、假体类型、固定类型和骨切除百分比)。均无统计学意义。胫骨切除少于40%的患者5年假体生存率较好。非骨水泥柄固定的耐久性超过骨水泥柄。翻修后假体8年预期生存率为52%。肢体缺失的主要原因是感染。软组织重建不满意导致了大多数失败。需要积极的多阶段感染管理。人工膝关节置换最适合需要化疗的癌症患者以及潜在生存期短的患者。